Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News
Links shared publicly online about this topic.
- 240total visits
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News
View full resource at internalmedicinenews.com
Tags: Heart, Cancer, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin, News, Medical
Most Recently Shared on June 5, 2011 at 11:58 pm By:
RT @IntMedNews: Bevacizumab Halves Progression Risk in Recurrent Ovarian #Cancer http://bit.ly/ipBNsP
Advertisement

